Visceral adiposity and cardiometabolic risks: epidemic of abdominal obesity in North America

References

• Dawber TR, Meadors GF, Moore FE Jr. Epidemiological approaches to heart disease: the Framingham study. Am JPublic Health Nations Health. 1951;41:279–281.
   PubMed Web of Science ®Google Scholar
• Kannel WB. Some lessons in cardiovascular epidemiology from Framingham. Am J Cardiol 1976;37(2):269–282.
   PubMed Web of Science ®Google Scholar
• Block JP, DeSalvo KB, Fisher WP. Are physicians equipped to address the obesity epidemic? Knowledge and attitudes of internal medicine residents. PrevMed. 2003;36(6):669–675.
   PubMed Web of Science ®Google Scholar
• Story MT, Neumark-Stzainer DR, Sherwood NE, et al. Management of child and adolescent obesity: attitudes, barriers, skills, and training needs among health care professionals. Pediatrics. 2002;110(1 Pt 2):210–214.
   PubMed Web of Science ®Google Scholar
• Stice E, Shaw H, Marti CN. A meta-analytic review of obesity prevention programs for children and adolescents: the skinny on interventions that work. Psychol Bull. 2006;132(5):667–691.
   PubMed Web of Science ®Google Scholar
• Christakis NA, Fowler JH. The spread of obesity in a large social network over 32 years. N Engl J Med. 2007;357(4):370–379.
   PubMed Web of Science ®Google Scholar
• Carmo C, Sa H, Xavier da Cunha MF, Campos M. Alpha-interferon renal toxicity. Nefrologia. 2005;25(6):718–719.
   Web of Science ®Google Scholar
• Sa HS, Cho HY, Kang SW. Optical coherence tomography of idiopathic polypoidal choroidal vasculopathy. Korean J Ophthalmol. 2005;19(4):275–280.
   Google Scholar
• Ogden CL, Flegal KM, Carroll MD, Johnson CL. Prevalence and trends in overweight among US children and adolescents, 1999–2000. JAMA. 2002;288(14):1728–1732.
   PubMed Web of Science ®Google Scholar
• Sá H, Freitas L, Mota A, Cunha F, Marques A. Primary antiphospholipid syndrome presented by total infarction of right kidney with nephrotic syndrome. Clin Nephrol. 1999;52(1):56–60.
   Web of Science ®Google Scholar
• Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999–2000. JAMA. 2002;288(14):1723–1727.
   PubMed Web of Science ®Google Scholar
• Katzmarzyk PT. The Canadian obesity epidemic: an historical perspective. Obes Res. 2002;10(7):666–674.
   Google Scholar
• Wang Y, Mi J, Shan XY, Wang QJ, Ge KY. Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China. Int J Obes (Lond). 2007;31(1):177–188.
   Web of Science ®Google Scholar
• Duncan DT, Wolin KY, Scharoun-Lee M, Ding EL, Warner ET, Bennett GG. Does perception equal reality? Weight misperception in relation to weight-related attitudes and behaviors among overweight and obese US adults. Int JBehav Nutr Phys Act. 2011;8:20.
   PubMed Web of Science ®Google Scholar
• Shields M, Carroll MD, Ogden CL. Adult obesity prevalence in Canada and the United States. NCHSData Brief. 2011;56:1–8.
   PubMedGoogle Scholar
• Tremblay MS, Pérez CE, Ardern CI, Bryan SN, Katzmarzyk PT. Obesity, overweight and ethnicity. Health Rep. 2005;16(4):23–34.
   PubMedGoogle Scholar
• Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999–2008. JAMA. 2010;303(3):235–241.
   PubMed Web of Science ®Google Scholar
• HHS.gov. Prevalence of obesity. Office of Minority Health Department of Health and Human Services. 2010. http://www.minorityhealth.hhs.gov/templates/content.aspx10=6456.
   Google Scholar
• Colditz GA, Willett WC, Stampfer MJ, et al. Weight as a risk factor for clinical diabetes in women. Am J Epidemiol. 1990;132(3):501–513.
   PubMed Web of Science ®Google Scholar
• Kolotkin RL, Crosby RD. Psychometric evaluation of the impact of weight on quality of life-lite questionnaire (IWQOL-lite) in a community sample. Qual Life Res. 2002;11(2):157–171.
   PubMed Web of Science ®Google Scholar
• Manson JE, Willett WC, Stampfer MJ, et al. Body weight and mortality among women. N Engl J Med. 1995;333(11):677–685.
   PubMed Web of Science ®Google Scholar
• Fabricatore AN, Wadden TA, Rohay JM, et al. Weight loss expectations and goals in a population sample of overweight and obese US adults. Obesity (Silver Spring). 2008;16(11):2445–2450.
   Web of Science ®Google Scholar
• Nicklas BJ, Penninx BW, Cesari M, et al. Association of visceral adipose tissue with incident myocardial infarction in older men and women: the Health, Aging and Body Composition Study. Am J Epidemiol. 2004;160(8):741–749.
   Web of Science ®Google Scholar
• Kuk JL, Katzmarzyk PT, Nichaman MZ, Church TS, Blair SN, Ross R. Visceral fat is an independent predictor of all-cause mortality in men. Obesity (Silver Spring). 2006;14(2):336–341.
   PubMed Web of Science ®Google Scholar
• Cnop M, Havel PJ, Utzschneider KM, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia. 2003;46(4):459–469.
   PubMed Web of Science ®Google Scholar
• Despres JP, Lemieux I, Prud’homme D. Treatment of obesity: need to focus on high risk abdominally obese patients. BMJ. 2001;322(7288):716–720.
   PubMedGoogle Scholar
• Brandle M, Zhou H, Smith BR, et al. The direct medical cost of type 2 diabetes. Diabetes Care. 2003;26(8):2300–2304.
   PubMed Web of Science ®Google Scholar
• Gilmer TP, O’Connor PJ, Rush WA, et al. Predictors of health care costs in adults with diabetes. Diabetes Care. 2005;28(1):59–64.
   Web of Science ®Google Scholar
• Vijan S, Hayward RA, Langa KM. The impact of diabetes on workforce participation: results from a national household sample. Health Serv Res. 2004;39(6 Pt 1):1653–1669.
   Web of Science ®Google Scholar
• Betz MD. Enriching Health: Pathways to Complementary Therapies. Bloomington IN: Authorhouse; 2006.
   Google Scholar
• Daviglus ML. Health care costs in old age are related to overweight and obesity earlier in life. Health Aff (Millwood). 2005;24 Suppl 2:W5R97–100.
   Web of Science ®Google Scholar
• Popkin BM, Kim S, Rusev ER, Du S, Zizza C. Measuring the full economic costs of diet, physical activity and obesity-related chronic diseases. Obes Rev. 2006;7(3):271–293.
   PubMed Web of Science ®Google Scholar
• Hojgaard B, Olsen KR, Sogaard J, Gyrd-Hansen D, Sorensen TI. Obesity related health care costs assessed from BMI or waist circumference - secondary publication. Ugeskr Laeger. 2009;171(43):3068–3071. Danish.
   Google Scholar
• Bigaard J, et al. Waist circumference, BMI, smoking, and mortality in middle-aged men and women. Obes Res. 2003;11(7):895–903.
   Google Scholar
• Pouliot MC et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol. 1994;73(7):460–468.
   Web of Science ®Google Scholar
• Wimalawansa SJ. Thermogenesis - based interventions for obesity and type 2 diabetes. Expert Reviewers of Endocronology and Metabolism. (In Press).
   Google Scholar
• Lewiiiski A, Brona A, Lewnadowski K, Skowronska-JoZwiak E, Milewicz A. In contrast to matrix metalloproteinases, serum adiponectin concentrations increase after radioiodine treatment of thyrotoxicosis. Thyroid Res. 2012;5(1):12.
   Google Scholar
• Memon S, A Memon MM. Spectrum and immediate outcome of seizures in neonates. J Coll Physicians Surg Pak 2006;16(11):717–720.
   Google Scholar
• A S, T I, A M, T W, J P. The arterial vascularization of the stomach fundus of human fetuses. Folia Morphol (Warsz). 1999;58(3):191–198.
   Google Scholar
• Korner J, Aronne LJ. The emerging science of body weight regulation and its impact on obesity treatment. J Clin Invest. 2003;111(5):565–570.
   PubMed Web of Science ®Google Scholar
• Aronne LJ. Therapeutic options for modifying cardiometabolic risk factors. Am J Med. 2007;120(3 Suppl 1):S26-S34.
   Web of Science ®Google Scholar
• Willett WC, Manson JE, Stampfer MJ, et al. Weight, weight change, and coronary heart disease in women. Risk within the ‘normal’ weight range. JAMA. 1995;273(6):461–465.
   PubMed Web of Science ®Google Scholar
• Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med. 1995;122(7):481–486.
   PubMed Web of Science ®Google Scholar
• Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999–2010. JAMA. 2012;307(5):483–490.
   PubMed Web of Science ®Google Scholar
• Koebnick C, Smith N, Coleman KJ, et al. Prevalence of extreme obesity in a multiethnic cohort of children and adolescents. J Pediatr. 2010;157(1):26–31.
   PubMed Web of Science ®Google Scholar
• Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the United States: prevalence and trends, 1960–1994. Int J Obes Relat Metab Disord. 1998;22(1):39–47.
   PubMed Web of Science ®Google Scholar
• Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA. 2006;295(13):1549–1555.
   PubMed Web of Science ®Google Scholar
• Wilson PW, D’Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med. 2002;162(16):1867–1872.
   PubMedGoogle Scholar
• Schiller JS, Lucas JW, Ward BW, Peregoy JA. Summary Health Statistics for US Adults: National Health Interview Survey, 2010. Hyattsville, MD: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2012. Available from: http://www.cdc.gov/nchs/data/series/sr_10/sr10_252.pdf. Accessed February 18, 2013.
   Google Scholar
• Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA. 2012;307(5):491–497.
   PubMed Web of Science ®Google Scholar
• Pascot A, Lemieux I, Prud’homme D, et al. Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity. J Lipid Res. 2001;42(12):2007–2014.
   Web of Science ®Google Scholar
• Lemieux I, Pascot A, Prud’homme D, et al. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol. 2001;21(6):961–967.
   Web of Science ®Google Scholar
• Couillard C, Bergeron N, Prud’homme D, et al. Postprandial triglyceride response in visceral obesity in men. Diabetes. 1998;47(6):953–960.
   Web of Science ®Google Scholar
• The Practical Guide: Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Bethesda, MD: National Institutes of Health; 2000. Available from: http://www.nhlbi.nih.gov/guidelines/obesity/prctgd_c.pdf. Accessed February 13, 2013.
   Google Scholar
• Marks R, Allegrante JP. Body mass indices in patients with disabling hip osteoarthritis. Arthritis Res. 2002;4(2):112–116.
   Google Scholar
• Pi-Sunyer FX. Medical hazards of obesity. Ann Intern Med. 1993;119(7 Pt 2):655–660.
   Web of Science ®Google Scholar
• Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40(6):1387–1395.
   PubMed Web of Science ®Google Scholar
• De Waele B, Vanmierlo B, Van Nieuwenhove Y, Delvaux G. Impact of body overweight and class I, II and III obesity on the outcome of acute biliary pancreatitis. Pancreas. 2006;32(4):343–345.
   Web of Science ®Google Scholar
• Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Prospective study of abdominal adiposity and gallstone disease in US men. Am J Clin Nutr. 2004;80(1):38–44.
   Web of Science ®Google Scholar
• Alvarez-Blasco F, Botella-Carretero JI, San Millan JL, Escobar- Morreale HF. Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women. Arch Intern Med. 2006;166(19):2081–2086.
   PubMedGoogle Scholar
• Lopez-Casasnovas G, Rivera B, Currais L, editors. Health and Economic Growth: Findings and Policy Implications. Massachusetts: The MIT Press; 2005.
   Google Scholar
• Bloom DE, Canning D, Sevilla J. The Effect of Health on Economic Growth: Theory and Evidence. World Dev. 2004;32(1):1–13.
   Web of Science ®Google Scholar
• Ogden CL, Carroll MD, Flegal KM. High body mass index for age among US children and adolescents, 2003–2006. JAMA. 2008;299(20):2401–2405.
   PubMed Web of Science ®Google Scholar
• Mei Z, Scanlon KS, Grummer-Strawn LM, Freedman DS, Yip R, Trowbridge FL. Increasing prevalence of overweight among US low-income preschool children: the Centers for Disease Control and Prevention pediatric nutrition surveillance, 1983 to 1995. Pediatrics. 1998;101(1):E12.
   PubMed Web of Science ®Google Scholar
• Ogden CL, Troiano RP, Briefel RR, Kuczmarski RJ, Flegal KM, Johnson CL. Prevalence of overweight among preschool children in the United States, 1971 through 1994. Pediatrics. 1997;99(4):E1.
   Google Scholar
• Austin SB, Melly SJ, Sanchez BN, Patel A, Buka S, Gortmaker SL. Clustering of fast-food restaurants around schools: a novel application of spatial statistics to the study of food environments. Am J Public Health. 2005;95(9):1575–1581.
   PubMed Web of Science ®Google Scholar
• Lobstein T, Jackson-Leach R. Estimated burden of paediatric obesity and co-morbidities in Europe. Part 2. Numbers of children with indicators of obesity-related disease. Int J Pediatr Obes. 2006;1(1):33–41.
   Web of Science ®Google Scholar
• Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet. 1999;353(9170):2093–2099.
   PubMed Web of Science ®Google Scholar
• Carr A, Samaras K, Burton S, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS. 1998;12(7):F51-F58.
   PubMed Web of Science ®Google Scholar
• Alberti KG, Zimmet P, Shaw J. Metabolic syndrome - a new worldwide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23(5):469–480.
   PubMed Web of Science ®Google Scholar
• Grundy SM. Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab. 2004;89(6):2595–2600.
   PubMed Web of Science ®Google Scholar
• Hales CN, Barker DJ. The thrifty phenotype hypothesis. Br Med Bull. 2001;60:5–20.
   PubMed Web of Science ®Google Scholar
• Hales CN, Desai M, Ozanne SE. The Thrifty Phenotype hypothesis: how does it look after 5 years? Diabet Med. 1997;14(3):189–195.
   Web of Science ®Google Scholar
• Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. NEJM.1995; 332(10):621–628.
   Google Scholar
• Janjua NZ, Mahmood B, Islam MA, Goldenberg RL. Maternal and early childhood risk factors for overweight and obesity among low-income predominantly black children at age five years: a prospective cohort study. JObes. 2012;2012:457173.
   Google Scholar
• Hales CN, Barker DJ. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia. 1992;35(7):595–601.
   PubMed Web of Science ®Google Scholar
• Wells JC. The thrifty phenotype hypothesis: thrifty offspring or thrifty mother? JTheorBiol. 2003;221(1):143–161.
   Web of Science ®Google Scholar
• Horing HU, Mehnert H. Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: candidates for a signal transmitter defect causing insulin resistance of the skeletal muscle. Diabetologia. 1993;36(3):176–182.
   Web of Science ®Google Scholar
• Jaquet D, Deghmoun S, Chevenne D, Czernichow P, Levy-Marchal C. Low serum adiponectin levels in subjects born small for gestational age: impact on insulin sensitivity. Int J Obes (Lond). 2006;30(1):83–87.
   PubMed Web of Science ®Google Scholar
• Levy-Marchal C, Czernichow P. Small for gestational age and the metabolic syndrome: which mechanism is suggested by epidemiological and clinical studies? Horm Res. 2006;65 Suppl 3:123–130.
   Google Scholar
• Mi J, Cheng H, Zhao XY, Hou DQ, Chen FF, Zhang KL. Developmental origin of metabolic syndrome: interaction of thinness at birth and overweight during adult life in Chinese population. Obes Rev. 2008;9 Suppl 1:91–94.
   Google Scholar
• Kerkhof GF, Leunissen RW, Hokken-Koelega AC. Early origins of the metabolic syndrome: role of small size at birth, early postnatal weight gain, and adult IGF-I. J Clin Endocrinol Metab. 2012;97(8):2637–2643.
   Web of Science ®Google Scholar
• Leunissen RW, Kerkhof GF, Stijnen T, Hokken-Koelega A. Timing and tempo of first-year rapid growth in relation to cardiovascular and metabolic risk profile in early adulthood. JAMA. 2009;301(21):2234–2242.
   PubMed Web of Science ®Google Scholar
• Ozanne SE, Jensen CB, Tingey KJ, Storgaard H, Madsbad S, Vaag AA. Low birthweight is associated with specific changes in muscle insulin-signalling protein expression. Diabetologia. 2005;48(3):547–552.
   Web of Science ®Google Scholar
• Santomauro AT, Boden G, Silva ME, et al. Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diabetes. 1999;48(9):1836–1841.
   Web of Science ®Google Scholar
• Boden G, Shulman GI. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest. 2002;32 Suppl 3:14–23.
   Google Scholar
• Rizzoni D, Muiesan ML, Porteri E, et al. Vascular remodeling, macro- and microvessels: therapeutic implications. Blood Press. 2009;18(5):242–246.
   PubMed Web of Science ®Google Scholar
• Pinto A, Tuttolomondo A, Parrinello G, Paterna S, Di Chiara T, Licata G. Prevalence, topographic distribution, and pathogenesis of macro- and microangiopathic vascular lesions in patients with diabetes mellitus. Retrospective study. Minerva Cardioangiol. 1999;47(12):581–582. Italian.
   Google Scholar
• Gallacher JE, Pickering J, Elwood PC, Bayer AJ, Yarnell JW, Ben-Shlomo Y. Glucoregulation has greater impact on cognitive performance than macro-vascular disease in men with type 2 diabetes: data from the Caerphilly study. Eur J Epidemiol. 2005;20(9):761–768.
   Web of Science ®Google Scholar
• Alexander CM, Landsman PB, Teutsch SM, Haffner SM; Third National Health and Nutrition Examination Survey (NHANES III); National Cholesterol Education Program (NCEP). NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes. 2003;52(5):1210–1214.
   PubMed Web of Science ®Google Scholar
• Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab. 2007;92(6):2017–2029.
   PubMed Web of Science ®Google Scholar
• Power C, Miller SK, Alpert PT. Promising new causal explanations for obesity and obesity-related diseases. Biol Res Nurs. 2007;8(3):223–233.
   Web of Science ®Google Scholar
• Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005;366(9497):1640–1649.
   PubMed Web of Science ®Google Scholar
• Bigaard J, Tjonneland A, Thomsen BL, Overvad K, Heitmann BL, Sorensen TI. Waist circumference, BMI, smoking, and mortality in middle-aged men and women. Obes Res. 2003;11(7):895–903.
   Google Scholar
• Janiszewski PM, Janssen I, Ross R. Does waist circumference predict diabetes and cardiovascular disease beyond commonly evaluated cardiometabolic risk factors? Diabetes Care. 2007;30(12):3105–3109.
   Web of Science ®Google Scholar
• Lemieux I, Pascot A, Couillard C, et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation. 2000;102(2):179–184.
   PubMed Web of Science ®Google Scholar
• Hawkins M, Rossetti S. Insulin resistance and its role in the pathogenesis of type 2 diabetes. In: Kahn CR, Weir GC, King G, Jacobson AM, Moses AC, Smith RJ, editors. Joslins Diabetes Mellitus, 14th ed. Boston, MA: Lippincott Williams & Wilkins; 2005:425–448.
   Google Scholar
• Riccardi G, Aggett P, Brighenti F, et al. PASSCLAIM - body weight regulation, insulin sensitivity and diabetes risk. Eur J Nutr. 2004; 43 Suppl 2:II7-II46.
   Web of Science ®Google Scholar
• Baik I. Optimal cutoff points of waist circumference for the criteria of abdominal obesity: comparison with the criteria of the International Diabetes Federation. Circ J. 2009;73(11):2068–2075.
   Web of Science ®Google Scholar
• Smith SC Jr, Haslam D. Abdominal obesity, waist circumference and cardio-metabolic risk: awareness among primary care physicians, the general population and patients at risk - the Shape of the Nations survey. Curr Med Res Opin. 2007;23(1):29–47.
   PubMed Web of Science ®Google Scholar
• Sturm R, Ringel JS, Lakdawalla DN, et al. Obesity and Disability: The Shape of Things to Come. Santa Monica, CA: RAND Corporation; 2007. Available from: http://www.rand.org/content/dam/rand/pubs/research_briefs/2007/RAND_RB9043–1.pdf. Accessed February 22, 2013.
   Google Scholar
• Alley DE, Chang VW, Doshi J. The shape of things to come: obesity, aging, and disability. LDI Issue Brief. 2008;13(3):1–4.
   Google Scholar
• Misra A, Vikram NK, Gupta R, Pandey RM, Wasir JS, Gupta VP. Waist circumference cutoff points and action levels for Asian Indians for identification of abdominal obesity. Int J Obes (Lond). 2006;30(1):106–111.
   Web of Science ®Google Scholar
• Li C, Ford ES, McGuire LC, Mokdad AH. Increasing trends in waist circumference and abdominal obesity among US adults. Obesity (Silver Spring). 2007;15(1):216–224.
   PubMed Web of Science ®Google Scholar
• Howel D. Waist circumference and abdominal obesity among older adults: patterns, prevalence and trends. PLoS One. 2012;7(10):e48528.
   Web of Science ®Google Scholar
• Carr DB, Utzschneider KM, Hull RL, et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes. 2004;53(8):2087–2094.
   PubMed Web of Science ®Google Scholar
• Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med. 2003;163(4):427–436.
   PubMedGoogle Scholar
• Minocci A, Guzzaloni G, Marzullo P, et al. Abdominal fat index by ultrasound does not estimate the metabolic risk factors of cardiovascular disease better than waist circumference in severe obesity. Diabetes Metab. 2005;31(5):471–477.
   Web of Science ®Google Scholar
• McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet. 1991;337(8738):382–386.
   PubMed Web of Science ®Google Scholar
• Dudeja V Misra A, Pandey RM, Devina G, Kumar G, Vikram NK. BMI does not accurately predict overweight in Asian Indians in northern India. Br JNutr. 2001;86(1):105–112.
   PubMed Web of Science ®Google Scholar
• Kusuma YS, Babu BV, Naidu JM. Chronic energy deficiency in some low socio-economic populations from South India: relationships between body mass index, waist-hip ratio and conicity index. Homo. 2008;59(1):67–79.
   Web of Science ®Google Scholar
• Ross R, Freeman J, Hudson R, Janssen I. Abdominal obesity, muscle composition, and insulin resistance in premenopausal women. J Clin Endocrinol Metab. 2002;87(11):5044–5051.
   PubMed Web of Science ®Google Scholar
• Bacha F, Saad R, Gungor N, Janosky J, Arslanian SA. Obesity, regional fat distribution, and syndrome X in obese black versus white adolescents: race differential in diabetogenic and atherogenic risk factors. J Clin Endocrinol Metab. 2003;88(6):2534–2540.
   Web of Science ®Google Scholar
• Prentki M, Nolan CJ. Islet beta cell failure in type 2 diabetes. J Clin Invest. 2006;116(7):1802–1812.
   PubMed Web of Science ®Google Scholar
• Pascotto M, Wei K, Micari A, Bragadeesh T, Goodman NC, Kaul S. Phasic changes in arterial blood volume is influenced by collateral blood flow: implications for the quantification of coronary stenosis at rest. Heart. 2007;93(4):438–443.
   Web of Science ®Google Scholar
• Després JP Is visceral obesity the cause of the metabolic syndrome? Ann Med. 2006;38(1):52–63.
   PubMed Web of Science ®Google Scholar
• Mertens I, Van der Planken M, Corthouts B, Van Gaal LF. Is visceral adipose tissue a determinant of von Willebrand factor in overweight and obese premenopausal women? Metabolism. 2006;55(5):650–655.
   Web of Science ®Google Scholar
• Couillard C, Ruel G, Archer WR, et al. Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity. J Clin Endocrinol Metab. 2005;90(12):6454–6459.
   PubMed Web of Science ®Google Scholar
• Lamarche B, Tchernof A, Mauriège P, et al. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA. 1998;279(24):1955–1961.
   Web of Science ®Google Scholar
• Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444(7121):881–887.
   PubMed Web of Science ®Google Scholar
• Mechanick JI, Kushner RF, Sugerman HJ, et al; American Association of Clinical Endocrinologists; Obesity Society; American Society for Metabolic and Bariatric Surgery. Executive summary of the recommendations of the American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic and Bariatric Surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Endocr Pract. 2008;14(3):318–336.
   Google Scholar
• Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724–1737.
   PubMed Web of Science ®Google Scholar
• Buchwald H; Consensus Conference Panal. Consensus conference statement bariatric surgery for morbid obesity: health implications for patients, health professionals, and third-party payers. Surg Obes Relat Dis. 2005;1(3):371–381.
   Google Scholar
• Mittelman SD, Van Citters GW, Kirkman EL, Bergman RN. Extreme insulin resistance of the central adipose depot in vivo. Diabetes. 2002;51(3):755–761.
   Web of Science ®Google Scholar
• Bjorntorp P. “Portal” adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis. 1990;10(4):493–496.
   Google Scholar
• Flier JS. The adipocyte: storage depot or node on the energy information superhighway? Cell. 1995;80(1):15–18.
   Web of Science ®Google Scholar
• Szmitko PE, Teoh H, Stewart DJ, Verma S. Adiponectin and cardiovascular disease: state of the art? Am J Physiol Heart Circ Physiol. 2007;292(4):H1655-H1663.
   Web of Science ®Google Scholar
• Greenstein AS, Khavandi K, Withers SB, et al. Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation. 2009;119(12):1661–1670.
   PubMed Web of Science ®Google Scholar
• Girn HR, Orsi NM, Homer-Vanniasinkam S. An overview of cytokine interactions in atherosclerosis and implications for peripheral arterial disease. Vasc Med. 2007;12(4):299–309.
   PubMed Web of Science ®Google Scholar
• Kahn R, Buse J, Ferrannini E, Stem M; American Diabetes Association; European Association for the Study of Diabetes. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005;28(9):2289–2304.
   PubMed Web of Science ®Google Scholar
• Hsu LA, Chang CJ, Wu S, et al. Association between functional variants of the ICAM1 and CRP genes and metabolic syndrome in Taiwanese subjects. Metabolism. 2010;59(12):1710–1716.
   Web of Science ®Google Scholar
• Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112(12):1796–1808.
   PubMed Web of Science ®Google Scholar
• Côté M, Mauriège P, Bergeron J, et al. Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men. J Clin Endocrinol Metab. 2005;90(3):1434–1439.
   Web of Science ®Google Scholar
• Després JP Inflammation and cardiovascular disease: is abdominal obesity the missing link? Int J Obes Relat Metab Disord. 2003; 27 Suppl 3:S22-S24.
   Google Scholar
• Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res. 2005;96(9):939–949.
   PubMed Web of Science ®Google Scholar
• Matsuzawa Y. Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nat Clin Pract Cardiovasc Med. 2006;3(1):35–42.
   PubMedGoogle Scholar
• Pascot A, Lemieux S, Lemieux I, et al. Age-related increase in visceral adipose tissue and body fat and the metabolic risk profile of premenopausal women. Diabetes Care. 1999;22(9):1471–1478.
   PubMed Web of Science ®Google Scholar
• Zamboni M, Armellini F, Milani MP, et al. Body fat distribution in pre- and post-menopausal women: metabolic and anthropometric variables and their inter-relationships. Int J Obes Relat Metab Disord. 1992;16(7):495–504.
   PubMedGoogle Scholar
• Arsenault BJ, et al. Visceral adipose tissue accumulation, cardiorespiratory fitness, and features of the metabolic syndrome. Arch Intern Med. 2007;167(14):1518–1525.
   PubMedGoogle Scholar
• Smith JD et al. Visceral adipose tissue indicates the severity of cardiometabolic risk in patients with and without type 2 diabetes: results from the INSPIRE ME IAA study. J Clin Endocrinol Meta. 2012;97(5):1517–1525.
   PubMed Web of Science ®Google Scholar
• Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444(7121):881–887.
   PubMed Web of Science ®Google Scholar
• Tchernof A, Després JP. Sex steroid hormones, sex hormone- binding globulin, and obesity in men and women. Horm Metab Res. 2000;32(11–12):526–536.
   Web of Science ®Google Scholar
• Lemieux I. Energy partitioning in gluteal-femoral fat: does the metabolic fate of triglycerides affect coronary heart disease risk? Arterioscler Thromb Vasc Biol. 2004;24(5):795–797.
   Web of Science ®Google Scholar